References
Bunin JJ, McGuire TF, Laster L, La Du BN, Seegmiller JE (1957) Alkaptonuria: clinical staft conference at the National Institutes of Health. Ann Int Med 47:1210–1224
La Du BN, Zannoni VG, Laster L, Seegmiller JE (1958) The nature of the defect in tyrosine metabolism in alkaptonuria. J Biol Chem 230:251–260
Levine M (1986) New concepts in the biology and biochemistry of ascorbic acid. N Engl J Med 314:892–902
Sealock RR, Galdston M, Steele JM (1940) Administration of ascorbic acid to an alkaptonuria patient. Proc Soc Exp Biol Med 44:580–583
Wolff JA, Barshop B, Nyhan WL, Lesli J, Seegmiller JE, Gruber H, Garst M, Winter S, Michals K, Matalon R (1989) Effects of ascorbic acid in alkaptonuria: alterations in benzoquinone acetic acid and an ontogenic effect in infancy. Pediatr Res 26: 140–144
Zannoni VG, Lomtevas V, Goldfinger S (1969) Oxidation of homogentisic acid to ochronotic pigment in connective tissue. Biochim Biophys Acta 177:94–105
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kamoun, P., Coude, M., Forest, M. et al. Ascorbic acid and alkaptonuria. Eur J Pediatr 151, 149 (1992). https://doi.org/10.1007/BF01958966
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01958966